Facebook Inc (FB) 95.68 $FB Yahoo! Unveils Mobile

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Facebook Inc (FB) 95.68 $FB

Yahoo! Unveils Mobile Messaging App, Livetext
at The Street - 21 mins ago
Yahoo! unveiled its entry into the messaging space, with Livetext as it seeks to get a portion of the messaging revenue space.
YHOO: 37.74 (+0.02), FB: 95.68 (+0.39), BBRY: 8.06 (+0.26), MSFT: 46.40 (+1.06)

Overpriced and Vulnerable: 9 Stocks to Avoid
at The Street - 27 mins ago
A look at the high-priced and weak among the most expensive sectors.
RATE: 9.22 (+0.02), BIDU: 168.27 (+0.24), LNKD: 227.28 (-1.22), FB: 95.68 (+0.39), AZN: 32.83 (+0.02), PBPB: 13.74 (+0.31), PLAY: 38.26 (+0.06), BWLD: 193.65 (+22.37), PLKI: 58.89 (+1.02), YUM: 87.83 (+0.88), WEN: 10.30 (+0.06)

PayPal Faces New Threat as Visa Partners With Payments Startup Stripe
at The Street - 50 mins ago
The big credit card networks prefer Stripe because it doesn't seek to develop its own relationship with their customers.
V: 76.18 (+1.44), EBAY: 28.72 (+0.39), AXP: 75.82 (+0.71), FB: 95.68 (+0.39), PYPL: 37.95 (+0.35), BABA: 80.77 (+0.21)

Stocks Open Up In Soft Trade; Earnings Stir Big Moves
at Investor's Business Daily - 1 hr 6 mins ago
The market opened to slender gains Wednesday, as earnings reports triggered big moves up and down across a broad swath of industry sectors. The Dow Jones industrial average rose 0.3%. The S&P 500 added 0.2%, and the Nasdaq clung to a gain of less...
GD: 151.06 (+6.77), MCK: 225.49 (-1.25), CHRW: 70.81 (+4.08), PNRA: 205.40 (+18.41), FB: 95.68 (+0.39), AKAM: 69.72 (-3.93), NOC: 174.45 (+11.11), GMCR: 74.51 (+2.71), MET: 57.22 (+0.95), SKX: 125.00 (+0.45), NXPI: 91.62 (+0.58), BWLD: 193.65 (+22.37), CTXS: 76.33 (+6.70), VDSI: 21.01 (-5.54), VRSK: 78.97 (+5.73), SPR: 55.09 (+2.22), DATA: 103.28 (-23.79), YELP: 23.93 (-9.58), TWTR: 31.74 (-4.80)

Twitter's Q2 Loss Lower Than Expected, Revenues Beat - Analyst Blog
Zacks Equity Research - Zacks Investment Research - 1 hr 57 mins ago
Twitter, Inc. (TWTR) reported second-quarter 2015 loss of 19 cents per share, which compared favorably with the Zacks Consensus Estimate of a loss of 24 cents.
YHOO: 37.74 (+0.02), FB: 95.68 (+0.39), GOOGL: 655.86 (-3.80), TWTR: 31.74 (-4.80)

Make Sure You Don't Get Caught in a Breakdown
at The Street - 2 hrs 26 mins ago
Nothing much sticks out to the upside right now.
BIIB: 310.36 (-9.57), ESPR: 65.30 (-3.71), VDSI: 21.01 (-5.54), FB: 95.68 (+0.39), BEAT: 11.80 (-0.19), DATA: 103.28 (-23.79)

The Future of Television Lies in Your Wristwatch and Social Network
at The Street - Wed Jul 29, 8:33AM CDT
Here are two ways in which programmers increasingly will deliver video content to consumers.
FB: 95.68 (+0.39), TWTR: 31.74 (-4.80)

Lithia Motors, Qualcomm, Twitter, Gilead and Facebook highlighted as Zacks Bull and Bear of the Day - Press Releases
Zacks Equity Research - Zacks Investment Research - Wed Jul 29, 8:30AM CDT
Lithia Motors, Qualcomm, Twitter, Gilead and Facebook highlighted as Zacks Bull and Bear of the Day
LAD: 115.85 (+3.26), GILD: 116.36 (+3.29), FB: 95.68 (+0.39), QCOM: 63.05 (-0.05), TWTR: 31.74 (-4.80)

LinkedIn Q2 Earnings Come Amid Rough Transition
at Investor's Business Daily - Wed Jul 29, 7:02AM CDT
LinkedIn (LNKD), the networking site for professionals, is aiming to update its resume with improved earnings for Q2, after its Q1 didn't get the job done. Though LinkedIn beat estimates when it reported Q1 earnings after the close April 30, the...
LNKD: 227.28 (-1.22), FB: 95.68 (+0.39), TWTR: 31.74 (-4.80)

Facebook Earnings Preview: The Big Driver Is Still Mobile
at The Street - Wed Jul 29, 6:44AM CDT
Facebook second-quarter results are poised to show that the social network giant continues to attract enormous amounts of ad revenue.
FB: 95.68 (+0.39), GOOGL: 655.86 (-3.80), GOOG: 625.70 (-2.30)

Top 10 New Stocks to Trade Like Hedge Fund Renaissance Technologies
at The Street - Wed Jul 29, 6:40AM CDT
Here's a closer look at Renaissance Technologies' 10 largest new holdings in the most recently reported quarter.
CCI: 82.29 (+0.03), AMZN: 527.09 (+1.06), FB: 95.68 (+0.39), PFE: 35.66 (+0.31), VFC: 75.32 (-0.33), WMT: 72.41 (+0.31), TWTR: 31.74 (-4.80), UNP: 97.20 (+0.58), REGN: 541.25 (-11.20), PCLN: 1,215.14 (+7.05)

3 Questions for Facebook, Inc. CEO Mark Zuckerberg Today
Daniel Sparks, The Motley Fool - Motley Fool - Wed Jul 29, 6:21AM CDT
With Facebook stock up about 16% in the past three months and 25% in the past 12 months, investors will be watching the company's second-quarter earnings release closely on Wednesday. Even more, beyond looking for the social network to meet or...
FB: 95.68 (+0.39)

'Fast Money' Recap: Twitter's Tough Year Continues
at The Street - Wed Jul 29, 4:00AM CDT
The trading panel discussed Facebook and earnings from Yelp and Panera Bread.
PNRA: 205.40 (+18.41), FB: 95.68 (+0.39), CMG: 736.73 (+5.95), GOOGL: 655.86 (-3.80), YELP: 23.93 (-9.58), TWTR: 31.74 (-4.80), PCLN: 1,215.14 (+7.05)

Jim Cramer's 'Mad Money' Recap: Bulls Rout the Bears, but Will It Last?
at The Street - Tue Jul 28, 7:20PM CDT
At least for one day, good news rules, Cramer says.
DHI: 28.21 (+0.62), AMZN: 527.09 (+1.06), CLR: 34.47 (+1.12), KODK: 14.00 (-0.03), FB: 95.68 (+0.39), AGCO: 54.28 (+2.04), SFL: 16.95 (+0.30), HABT: 29.18 (+0.35), MAS: 26.05 (+0.42), CLB: 110.90 (-1.14), NFLX: 106.69 (-0.21), JACK: 93.00 (+1.43), BIDU: 168.27 (+0.24), CMI: 128.75 (+0.75), CMG: 736.73 (+5.95), NAT: 15.21 (-0.20), ENB: 42.80 (-0.03), GOOGL: 655.86 (-3.80), CAT: 77.08 (-0.70), TASR: 30.97 (+0.19)

What to Watch Wednesday -- FOMC Policy, Facebook Results
at The Street - Tue Jul 28, 7:15PM CDT
On July 29, look for an announcement following the Federal Open Market Committee meeting and earnings from Facebook, MasterCard, Northrop Grumman, Anthem, MetLife and Wynn Resorts.
ANTM: 154.42 (+0.22), NOC: 174.45 (+11.11), FB: 95.68 (+0.39), MET: 57.22 (+0.95), WYNN: 98.15 (+0.14), MA: 95.90 (+0.74)

Facebook Internet.org One Year Old, Expansion in Full Swing - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 28, 5:22PM CDT
Facebook, Inc.'s (FB) Internet.org initiative completed a year on Monday and along with it came the company's latest expansion plan for its free Internet service.
FB: 95.68 (+0.39), QCOM: 63.05 (-0.05), EXPE: 106.41 (-0.76), NOK: 6.54 (-0.08)

Google+ Accounts Not Required for Other Google Products - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 28, 5:17PM CDT
Google (GOOGL) rolled out its own social networking platform, Google+ in 2011 in a bid to turn itself into one giant social network and compete with the likes of Facebook (FB) and Twitter (TWTR).
LC: 14.70 (-0.11), FB: 95.68 (+0.39), GOOGL: 655.86 (-3.80), TWTR: 31.74 (-4.80)

Online Shoppers Rank Free Shipping As Most Important
at Investor's Business Daily - Tue Jul 28, 4:43PM CDT
Nearly 80% of consumers would buy more online if e-commerce firms offered free shipping, a new survey by Morgan Stanley shows. Consumers value free shipping and delivery above all other e-commerce service offerings. Morgan Stanley's Q1 global survey...
AMZN: 527.09 (+1.06), FB: 95.68 (+0.39), GOOGL: 655.86 (-3.80), TWTR: 31.74 (-4.80), BABA: 80.77 (+0.21)

Twitter Beats on Earnings and Revenue - Stocks in the News
Zacks Research Staff - Zacks Investment Research - Tue Jul 28, 4:36PM CDT
Twitter released its latest earnings report after the closing bell today, beating our estimates for earnings and revenue.
FB: 95.68 (+0.39), TWTR: 31.74 (-4.80)

Were Chicken Fries Key to Burger King Sales Growth? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Jul 28, 3:32PM CDT
It seems Chicken Fries are back for Burger King -- and how!
JACK: 93.00 (+1.43), QSR: 42.89 (+0.14), FB: 95.68 (+0.39), TWTR: 31.74 (-4.80)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Innovent's Seven Drugs Leap onto 2026 Reimbursement Chart

Updated Category News Views 223

A Bold Move in Biopharmaceuticals Innovent Biologics just pulled a rabbit out of their hat. Seven of their cutting-edge meds made it onto China's National Reimbursement Drug List for 2026. This isn't just a spreadsheet entry—it's a lifeline thrown to patients across the oncology, metabolic, and autoimmune landscapes, as well as a financial booster for Innovent (HKEX:...

Continue Reading
CARsgen's CAR-T Breakthrough on China's Insurance List

Updated Category News Views 154

A Game Changer for CAR-T Therapies There's a breeze of optimism blowing from Shanghai these days—a rare sensation in this market of endless skirmishes. CARsgen Therapeutics Holdings Limited, a company entrenched in the development of cutting-edge CAR T-cell therapies, just notched a victory. They've announced that their CAR T-cell therapy product, satricabtagene...

Continue Reading
Fluence Energy Faces Leadership Departures Amid Legal Woes

Updated Category News Views 122

Fluence Energy's Rocky Road Continues It's chaos once again in the halls of Fluence Energy (NASDAQ:FLNC). The ship seems to drift further from solid ground as their CEO and CFO candidly decided to jump ship, shaking investor confidence even more vigorously. The market's reaction was swift and brutal: a nasty 9% share drop, leaving investors with more than just a headache....

Continue Reading
ManuTech Center Set to Revolutionize Manufacturing Hub

Updated Category News Views 207

Jackson's Next Manufacturing Frontier Well, the folks down in Jackson, Michigan, are prepping to cut the red ribbon on something that's got me leaning forward in my seat. The Advanced Manufacturing Training Center (AMTC) is pulling out all the stops with their new ManuTech Prototyping Center. Yup, this center is about to become the playground for startups, manufacturers,...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 22

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
SmallRig Boosts Art-Driven Innovation in AI Era

Updated Category News Views 148

The Interplay of Art and AI In a world where the lines between man and machine blur faster than ever, creators like SmallRig are boldly asking: what role should authenticity play when AI takes the stage? The Shenzhen International Art Museum and SmallRig stood shoulder to shoulder, tackling this head-scrambling question with a global gathering of art and tech giants. It's...

Continue Reading
WeFetch AI: A New Era in Barcode Precision

Updated Category News Views 225

WeFetch AI: What's in a Name? Forget about GreenCore Solutions Corp. We're talking about WeFetch AI Corp. now. They've just changed their name, fulfilling a bureaucratic tick as of November 13, 2026. But it ain't just a name change; it's a whole new ballgame in AI-driven commerce. AI Shopping Without the Guesswork We've all been there. You think you've ordered that...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 155

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading
EFICYENT Ventures to Connect at Singapore FinTech Fest

Updated Category News Views 150

Why the Singapore FinTech Festival Matters The world's hardly a stranger to hype, but the Singapore FinTech Festival carries some real weight. From November 18 to 20, 2026, this gig isn't just industry chatter—it's a high-stakes convergence of policymakers, financial institutions, fintech innovators like EFICYENT, and the money folk looking to mold the future of...

Continue Reading
Gaine Expands Healthcare Data Solutions Ahead of HLTH 2026

Updated Category News Views 233

Ever felt like healthcare systems are still stuck in a bygone era, struggling with data flinging through the void? Well, Gaine Technology is throwing down its gauntlet to change that narrative. Successful in pharmaceuticals and life sciences, they're turbocharging their Consent and Preference Management solution across the vast, tangled web of healthcare markets just in...

Continue Reading
les" class="btn" href="https://investorshangout.com/blog/news?page=2">More News Articles